Abstract | BACKGROUND: METHODS: Cytogenetic and molecular analyses were performed to reveal chromosomal and genetic alterations. Sequence alterations in the SETBP1, SF3B1, U2AF1, and SRSF2 genes were examined by using direct sequencing in a cohort of 53 childhood AML patients. RESULTS: Childhood AML patients did not harbor any recurrent SETBP1 gene mutations, although our study did identify a synonymous mutation in one patient. None of the previously reported aberrations in the mutational hotspot of SF3B1, U2AF1, and SRSF2 were identified in any of the 53 patients. CONCLUSIONS: Alterations of the SETBP1 gene or SF3B1, U2AF1, and SRSF2 genes are not common genetic events in childhood AML, implying that the mutations are unlikely to exert a driver effect in myeloid leukemogenesis during childhood.
|
Authors | Hyun-Woo Choi, Hye-Ran Kim, Hee-Jo Baek, Hoon Kook, Duck Cho, Jong-Hee Shin, Soon-Pal Suh, Dong-Wook Ryang, Myung-Geun Shin |
Journal | Annals of laboratory medicine
(Ann Lab Med)
Vol. 35
Issue 1
Pg. 118-22
(Jan 2015)
ISSN: 2234-3814 [Electronic] Korea (South) |
PMID | 25553291
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carrier Proteins
- Nuclear Proteins
- Phosphoproteins
- RNA Splicing Factors
- Ribonucleoprotein, U2 Small Nuclear
- Ribonucleoproteins
- SETBP1 protein, human
- SF3B1 protein, human
- Splicing Factor U2AF
- U2AF1 protein, human
- SRSF2 protein, human
- Serine-Arginine Splicing Factors
|
Topics |
- Adolescent
- Carrier Proteins
(genetics)
- Child
- Child, Preschool
- Cohort Studies
- Cytogenetic Analysis
- DNA Mutational Analysis
- Female
- Gene Frequency
- Genotype
- Humans
- Infant
- Leukemia, Myeloid, Acute
(genetics, pathology)
- Male
- Nuclear Proteins
(genetics)
- Phosphoproteins
(genetics)
- Polymorphism, Single Nucleotide
- RNA Splicing
- RNA Splicing Factors
- Ribonucleoprotein, U2 Small Nuclear
(genetics)
- Ribonucleoproteins
(genetics)
- Serine-Arginine Splicing Factors
- Splicing Factor U2AF
|